Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis

Abstract

Postmenopausal osteoporosis (PMO) is a prevalent metabolic bone disease characterized by bone loss and structural destruction, which increases the risk of fracture in postmenopausal women. Owing to the high morbidity and serious complications of PMO, many efforts have been devoted to its prophylaxis and treatment. The intestinal microbiota is the complex community of microorganisms colonizing the gastrointestinal tract. Probiotics, which are dietary or medical supplements consisting of beneficial intestinal bacteria, work in concert with endogenous intestinal microorganisms to maintain host health. Recent studies have revealed that bone loss in PMO is closely related to host immunity, which is influenced by the intestinal microbiota. The curative effects of probiotics on metabolic bone diseases have also been demonstrated. The effects of the intestinal microbiota on bone metabolism suggest a promising target for PMO management. This review seeks to summarize the critical effects of the intestinal microbiota and probiotics on PMO, with a focus on the molecular mechanisms underlying the pathogenic relationship between bacteria and host, and to define the possible treatment options.

Osteoporosis: Go with the gut

Probiotics may improve treatment of postmenopausal osteoporosis (PMO). In PMO, decreased estrogen levels weaken bones and increase the risk of fracture, usually of the hip, femur, or spine. Complications can be serious, and better prophylactic and treatment options are needed. The intestinal microbial community is known to affect bone formation, suggesting a new treatment avenue. Xuedong Zhou of Sichuan University, Chengdu, China and co-workers reviewed the evidence that probiotics might help combat PMO. They report that in PMO, low estrogen levels decrease microbial diversity and weaken the intestinal lining, opening the door for pathogens and triggering immune responses associated with bone loss. Treatment with probiotics ameliorates these effects, restoring intestinal diversity, normalizing immune responses, and increasing calcium absorption and production of estrogen-like compounds. The authors conclude that probiotics are a promising supplementary treatment for PMO.

References

[1] Watts NB, Bilezikian JP, Camacho PM et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract, 2010, 16 Suppl 3 1-37

[2] Forsen L, Sogaard AJ, Meyer HE et al. Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int, 1999, 10: 73-78

[3] Orwig DL, Chan J, Magaziner J. Hip fracture and its consequences: differences between men and women. Orthop Clin North Am, 2006, 37: 611-622

[4] Macari S, Duffles LF, Queiroz-Junior CM et al. Oestrogen regulates bone resorption and cytokine production in the maxillae of female mice. Arch Oral Biol, 2015, 60: 333-341

[5] Esfahanian V, Shamami MS, Shamami MS. Relationship between osteoporosis and periodontal disease: review of the literature. J Dent (Tehran), 2012, 9: 256-264

[6] LaMonte MJ, Hovey KM, Genco RJ et al. Five-year changes in periodontal disease measures among postmenopausal females: the Buffalo OsteoPerio study. J Periodontol, 2013, 84: 572-584

[7] Passos JS, Vianna MI, Gomes-Filho IS et al. Osteoporosis/osteopenia as an independent factor associated with periodontitis in postmenopausal women: a case-control study. Osteoporos Int, 2013, 24: 1275-1283

[8] Calciolari E, Mardas N, Dereka X et al. The effect of experimental osteoporosis on bone regeneration: part 2, proteomics results. Clin Oral Implants Res, 2017, 28: e135-e145

[9] Durao SF, Gomes PS, Colaco BJ et al. The biomaterial-mediated healing of critical size bone defects in the ovariectomized rat. Osteoporos Int, 2014, 25: 1535-1545

[10] Black DM, Rosen CJ. Clinical Practice. Postmenopausal Osteoporosis. N Engl J Med, 2016, 374: 254-262

[11] Deal C. Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol, 2009, 5: 20-27

[12] Sjogren K, Engdahl C, Henning P et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res, 2012, 27: 1357-1367

[13] Blanton LV, Charbonneau MR, Salih T et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science, 2016, 351: pii: aad3311

[14] Yan J, Herzog JW, Tsang K et al. Gut microbiota induce IGF-1 and promote bone formation and growth. Proc Natl Acad Sci USA, 2016, 113: E7554-e7563

[15] Guss JD, Horsfield MW, Fontenele FF et al. Alterations to the gut microbiome impair bone strength and tissue material properties. J Bone Miner Res, 2017, 32: 1343-1353

[16] Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464: 59-65

[17] Tojo R, Suarez A, Clemente MG et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol, 2014, 20: 15163-15176

[18] Org E, Parks BW, Joo JW et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res, 2015, 25: 1558-1569

[19] Kovacs A, Ben-Jacob N, Tayem H et al. Genotype is a stronger determinant than sex of the mouse gut microbiota. Microb Ecol, 2011, 61: 423-428

[20] Benson AK, Kelly SA, Legge R et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA, 2010, 107: 18933-18938

[21] Esworthy RS, Smith DD, Chu FF. A strong impact of genetic background on gut microflora in mice. Int J Inflam, 2010, 2010: 986046

[22] Goodrich JK, Waters JL, Poole AC et al. Human genetics shape the gut microbiome. Cell, 2014, 159: 789-799

[23] Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature, 2009, 457: 480-484

[24] Zhao L, Wang G, Siegel P et al. Quantitative genetic background of the host influences gut microbiomes in chickens. Sci Rep, 2013, 3: 1163

[25] Dabrowska K, Witkiewicz W. Correlations of host genetics and gut microbiome composition. Front Microbiol, 2016, 7: 1357

[26] Kashtanova DA, Popenko AS, Tkacheva ON et al. Association between the gut microbiota and diet: Fetal life, early childhood, and further life. Nutrition, 2016, 32: 620-627

[27] Schmidt B, Mulder IE, Musk CC et al. Establishment of normal gut microbiota is compromised under excessive hygiene conditions. PLoS One, 2011, 6: e28284

[28] Panda S, El khader I, Casellas F et al. Short-term effect of antibiotics on human gut microbiota. PLoS One, 2014, 9: e95476

[29] Cho I, Yamanishi S, Cox L et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature, 2012, 488: 621-626

[30] Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr, 1995, 125: 1401-1412

[31] Shin JH, Sim M, Lee JY et al. Lifestyle and geographic insights into the distinct gut microbiota in elderly women from two different geographic locations. J Physiol Anthropol, 2016, 35: 31

[32] Fujisaka S, Ussar S, Clish C et al. Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest, 2016, 126: 4430-4443

[33] Leamy LJ, Kelly SA, Nietfeldt J et al. Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice. Genome Biol, 2014, 15: 552

[34] Sekhon BS, Jairath S. Prebiotics, probiotics and synbiotics: an overview. J Pharm Educ Res, 2010, 1: 13-36

[35] Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr, 2000, 71: 1682S-1687S

[36] Salminen S, Bouley C, Boutron-Ruault MC et al. Functional food science and gastrointestinal physiology and function. Br J Nutr, 1998, 80 Suppl 1 S147-S171

[37] Gupta V, Garg R. Probiotics. Indian J Med Microbiol, 2009, 27: 202-209

[38] Roberfroid MB. Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr, 1998, 80: S197-S202

[39] Roberfroid M, Gibson GR, Hoyles L et al. Prebiotic effects: metabolic and health benefits. Br J Nutr, 2010, 104 Suppl 2 S1-63

[40] Plaza-Diaz J, Fernandez-Caballero JA, Chueca N et al. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients, 2015, 7: 3999-4015

[41] Ferrario C, Taverniti V, Milani C et al. Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr, 2014, 144: 1787-1796

[42] Zhang J, Wang L, Guo Z et al. 454 pyrosequencing reveals changes in the faecal microbiota of adults consuming Lactobacillus casei Zhang. FEMS Microbiol Ecol, 2014, 88: 612-622

[43] Unno T, Choi JH, Hur HG et al. Changes in human gut microbiota influenced by probiotic fermented milk ingestion. J Dairy Sci, 2015, 98: 3568-3576

[44] Rampelli S, Candela M, Severgnini M et al. A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging, 2013, 17: 166-172

[45] Ahmed M, Prasad J, Gill H et al. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging, 2007, 11: 26-31

[46] Chen D, Yang Z, Chen X et al. The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. BMC Complement Altern Med, 2014, 14: 386

[47] Lahti L, Salonen A, Kekkonen RA et al. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. Peer J, 2013, 1: e32

[48] Charbonneau D, Gibb RD, Quigley EM. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes, 2013, 4: 201-211

[49] Li JY, Chassaing B, Tyagi AM et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest, 2016, 126: 2049-2063

[50] Collins KH, Paul HA, Reimer RA et al. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model. Osteoarthritis Cartilage, 2015, 23: 1989-1998

[51] Cox LM, Yamanishi S, Sohn J et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell, 2014, 158: 705-721

[52] Phillips FC, Gurung P, Kanneganti TD. Microbiota and caspase-1/caspase-8 regulate IL-1beta-mediated bone disease. Gut Microbes, 2016, 7: 334-341

[53] Lukens JR, Gurung P, Vogel P et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature, 2014, 516: 246-249

[54] Crotti TN, Dharmapatni AA, Alias E et al. Osteoimmunology: major and costimulatory pathway expression associated with chronic inflammatory induced bone loss. J Immunol Res, 2015, 2015: 281287

[55] Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb), 2013, 23: 43-63

[56] Kim N, Takami M, Rho J et al. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med, 2002, 195: 201-209

[57] Geuking MB, Koller Y, Rupp S et al. The interplay between the gut microbiota and the immune system. Gut Microbes, 2014, 5: 411-418

[58] Peterson CT, Sharma V, Elmen L et al. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol, 2015, 179: 363-377

[59] Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol, 2015, 159: 122-127

[60] Ivanov II, Atarashi K, Manel N et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 2009, 139: 485-498

[61] Adamopoulos IE, Chao CC, Geissler R et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther, 2010, 12: R29

[62] Duque G, Huang DC, Dion N et al. Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res, 2011, 26: 1472-1483

[63] Wang Y, Nishida S, Elalieh HZ et al. Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res, 2006, 21: 1350-1358

[64] Wang Y, Bikle DD, Chang W. Autocrine and paracrine actions of IGF-I signaling in skeletal development. Bone Res, 2013, 1: 249-259

[65] Wang Y, Nishida S, Sakata T et al. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology, 2006, 147: 4753-4761

[66] Wu S, Yang W, De Luca F. Insulin-like growth factor-independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth. Endocrinology, 2015, 156: 2541-2551

[67] Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev, 2008, 29: 535-559

[68] Leder B. Gonadal steroids and bone metabolism in men. Curr Opin Endocrinol Diabetes Obes, 2007, 14: 241-246

[69] Imai Y, Youn MY, Kondoh S et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann NY Acad Sci, 2009, 1173 Suppl 1 E31-E39

[70] Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun, 2005, 328: 688-696

[71] Bliziotes M. Update in serotonin and bone. J Clin Endocrinol Metab, 2010, 95: 4124-4132

[72] Wang Q, Chen D, Nicholson P et al. The associations of serum serotonin with bone traits are age- and gender-specific. PLoS One, 2014, 9: e109028

[73] Gustafsson BI, Thommesen L, Stunes AK et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem, 2006, 98: 139-151

[74] Battaglino R, Fu J, Spate U et al. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res, 2004, 19: 1420-1431

[75] Neuman H, Debelius JW, Knight R et al. Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol Rev, 2015, 39: 509-521

[76] Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol, 2014, 817: 177-194

[77] Landete JM, Arques J, Medina M et al. Bioactivation of phytoestrogens: intestinal bacteria and health. Crit Rev Food Sci Nutr, 2016, 56: 1826-1843

[78] Tamura M, Hori S, Nakagawa H et al. Effects of an equol-producing bacterium isolated from human faeces on isoflavone and lignan metabolism in mice. J Sci Food Agric, 2016, 96: 3126-3132

[79] Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol, 2003, 41: 631-636

[80] Cassidy A, Brown JE, Hawdon A et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr, 2006, 136: 45-51

[81] Song KB, Atkinson C, Frankenfeld CL et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr, 2006, 136: 1347-1351

[82] Van de Wiele T, Vanhaecke L, Boeckaert C et al. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect, 2005, 113: 6-10

[83] Yano JM, Yu K, Donaldson GP et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 2015, 161: 264-276

[84] Morris HA, O'Loughlin PD, Anderson PH. Experimental evidence for the effects of calcium and vitamin D on bone: a review. Nutrients, 2010, 2: 1026-1035

[85] Zhu K, Prince RL. Calcium and bone. Clin Biochem, 2012, 45: 936-942

[86] Wastney ME, Martin BR, Peacock M et al. Changes in calcium kinetics in adolescent girls induced by high calcium intake. J Clin Endocrinol Metab, 2000, 85: 4470-4475

[87] Redmond J, Jarjou LM, Zhou B et al. Ethnic differences in calcium, phosphate and bone metabolism. Proc Nutr Soc, 2014, 73: 340-351

[88] Hodgkinson A, Aaron JE, Horsman A et al. Effect of oophorectomy and calcium deprivation on bone mass in the rat. Clin Sci Mol Med, 1978, 54: 439-446

[89] Hara T, Sato T, Oka M et al. Effects of ovariectomy and/or dietary calcium deficiency on bone dynamics in the rat hard palate, mandible and proximal tibia. Arch Oral Biol, 2001, 46: 443-451

[90] Shen V, Birchman R, Xu R et al. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats. Bone, 1995, 16: 149-156

[91] Goto S, Fujita Y, Hotta M et al. Influence of differences in the hardness and calcium content of diets on the growth of craniofacial bone in rats. Angle Orthod, 2015, 85: 969-979

[92] Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci, 2010, 47: 181-195

[93] Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev, 2005, 85: 373-422

[94] Alexander RT, Rievaj J, Dimke H. Paracellular calcium transport across renal and intestinal epithelia. Biochem Cell Biol, 2014, 92: 467-480

[95] Kuwabara A, Tanaka K. The role of gastro-intestinal tract in the calcium absorption. Clin Calcium, 2015, 25: 1607-1612

[96] Sheikh MS, Schiller LR, Fordtran JS. In vivo intestinal absorption of calcium in humans. Miner Electrolyte Metab, 1990, 16: 130-146

[97] Scholz-Ahrens KE, Ade P, Marten B et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr, 2007, 137: 838s-846s

[98] Gilman J, Cashman KD. The effect of probiotic bacteria on transepithelial calcium transport and calcium uptake in human intestinal-like Caco-2 cells. Curr Issues Intest Microbiol, 2006, 7: 1-5

[99] Kruger MC, Brown KE, Collett G et al. The effect of fructooligosaccharides with various degrees of polymerization on calcium bioavailability in the growing rat. Exp Biol Med (Maywood), 2003, 228: 683-688

[100] Nzeusseu A, Dienst D, Haufroid V et al. Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats. Bone, 2006, 38: 394-399

[101] Coudray C, Tressol JC, Gueux E et al. Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. Eur J Nutr, 2003, 42: 91-98

[102] Demigne C, Jacobs H, Moundras C et al. Comparison of native or reformulated chicory fructans, or non-purified chicory, on rat cecal fermentation and mineral metabolism. Eur J Nutr, 2008, 47: 366-374

[103] Whisner CM, Martin BR, Schoterman MH et al. Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br J Nutr, 2013, 110: 1292-1303

[104] Teramoto F, Rokutan K, Sugano Y et al. Long-term administration of 4G-beta-D-galactosylsucrose (lactosucrose) enhances intestinal calcium absorption in young women: a randomized, placebo-controlled 96-wk study. J Nutr Sci Vitaminol (Tokyo), 2006, 52: 337-346

[105] Fukushima A, Aizaki Y, Sakuma K. Short-chain fatty acids induce intestinal transient receptor potential vanilloid type 6 expression in rats and Caco-2 cells. J Nutr, 2009, 139: 20-25

[106] Fukushima A, Aizaki Y, Sakuma K. Short-chain fatty acids increase the level of calbindin-D9k messenger RNA in Caco-2 cells. J Nutr Sci Vitaminol (Tokyo), 2012, 58: 287-291

[107] Fukushima A, Ohta A, Sakai K et al. Expression of calbindin-D9k, VDR and Cdx-2 messenger RNA in the process by which fructooligosaccharides increase calcium absorption in rats. J Nutr Sci Vitaminol (Tokyo), 2005, 51: 426-432

[108] Ohta A, Motohashi Y, Ohtsuki M et al. Dietary fructooligosaccharides change the concentration of calbindin-D9k differently in the mucosa of the small and large intestine of rats. J Nutr, 1998, 128: 934-939

[109] Takasaki M, Inaba H, Ohta A et al. Dietary short-chain fructooligosaccharides increase calbindin-D9k levels only in the large intestine in rats independent of dietary calcium deficiency or serum 1,25 dihydroxy vitamin D levels. Int J Vitam Nutr Res, 2000, 70: 206-213

[110] Domon-Dell C, Wang Q, Kim S et al. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells. Gut, 2002, 50: 525-529

[111] Leonhard-Marek S, Becker G, Breves G et al. Chloride, gluconate, sulfate, and short-chain fatty acids affect calcium flux rates across the sheep forestomach epithelium. J Dairy Sci, 2007, 90: 1516-1526

[112] Uppal SK, Wolf K, Martens H. The effect of short chain fatty acids on calcium flux rates across isolated rumen epithelium of hay-fed and concentrate-fed sheep. J Anim Physiol Anim Nutr (Berl), 2003, 87: 12-20

[113] Weaver CM. Diet, gut microbiome, and bone health. Curr Osteoporos Rep, 2015, 13: 125-130

[114] Thompson DD, Simmons HA, Pirie CM et al. FDA Guidelines and animal models for osteoporosis. Bone, 1995, 17: 125s-133s

[115] Kurabayashi T, Fujimaki T, Yasuda M et al. Time-course of vertebral and femoral bone loss in rats administered gonadotrophin-releasing hormone agonist. J Endocrinol, 1993, 138: 115-125

[116] Wang Y, Yano T, Kikuchi A et al. Comparison of the effects of add-back therapy with various natural oestrogens on bone metabolism in rats administered a long-acting gonadotrophin-releasing hormone agonist. J Endocrinol, 2000, 165: 467-473

[117] Boyd SK, Davison P, Muller R et al. Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone, 2006, 39: 854-862

[118] Britton RA, Irwin R, Quach D et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol, 2014, 229: 1822-1830

[119] Kimoto-Nira H, Mizumachi K, Okamoto T et al. Influence of long-term consumption of a Lactococcus lactis strain on the intestinal immunity and intestinal flora of the senescence-accelerated mouse. Br J Nutr, 2009, 102: 181-185

[120] Ohlsson C, Engdahl C, Fåk F et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One, 2014, 9: e92368

[121] Parvaneh K, Ebrahimi M, Sabran MR et al. Probiotics (Bifidobacterium longum) increase bone mass density and upregulate sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy. Biomed Res Int, 2015, 2015: 897639

[122] Klinck J, Boyd SK. The magnitude and rate of bone loss in ovariectomized mice differs among inbred strains as determined by longitudinal in vivo micro-computed tomography. Calcif Tissue Int, 2008, 83: 70-79

[123] McCabe LR, Irwin R, Schaefer L et al. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol, 2013, 228: 1793-1798

[124] Bouxsein ML, Myers KS, Shultz KL et al. Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res, 2005, 20: 1085-1092

[125] Chiang S-S, Pan T-M. Antiosteoporotic effects of lactobacillus-fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J Agric Food Chem, 2011, 59: 7734-7742

[126] Li CY, Schaffler MB, Wolde-Semait HT et al. Genetic background influences cortical bone response to ovariectomy. J Bone Miner Res, 2005, 20: 2150-2158

[127] Iwaniec UT, Yuan D, Power RA et al. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. J Bone Miner Res, 2006, 21: 1068-1074

[128] Legette LL, Lee W-H, Martin BR et al. Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects. Menopause, 2011, 18: 923-931

[129] Denning TL, Norris BA, Medina-Contreras O et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol, 2011, 187: 733-747

[130] Pacifici R. Role of T cells in ovariectomy induced bone loss--revisited. J Bone Miner Res, 2012, 27: 231-239

[131] Cenci S, Weitzmann MN, Roggia C et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest, 2000, 106: 1229-1237

[132] Alaish SM, Smith AD, Timmons J et al. Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host. Gut Microbes, 2013, 4: 292-305

[133] Davenport ER, Cusanovich DA, Michelini K et al. Genome-wide association studies of the human gut microbiota. PLoS One, 2015, 10: e0140301

[134] Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes, 2012, 3: 4-14

[135] Collins FL, Irwin R, Bierhalter H et al. Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. PLoS One, 2016, 11: e0153180

[136] Fuhrman BJ, Feigelson HS, Flores R et al. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab, 2014, 99: 4632-4640

[137] Flores R, Shi J, Fuhrman B et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med, 2012, 10: 253

[138] Breban M. Gut microbiota and inflammatory joint diseases. Joint Bone Spine, 2016, 83: 645-649

[139] Atarashi K, Tanoue T, Shima T et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science, 2011, 331: 337-341

[140] Nagano Y, Itoh K, Honda K. The induction of Treg cells by gut-indigenous Clostridium. Curr Opin Immunol, 2012, 24: 392-397

[141] Preidis GA, Saulnier DM, Blutt SE et al. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J, 2012, 26: 1960-1969

[142] Schaefer L, Auchtung TA, Hermans KE et al. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology, 2010, 156: 1589-1599

[143] Kimoto-Nira H, Suzuki C, Kobayashi M et al. Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice. Br J Nutr, 2007, 98: 1178-1186

[144] Gonzalez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta, 2008, 1778: 729-756

[145] Muto S, Furuse M, Kusano E. Claudins and renal salt transport. Clin Exp Nephrol, 2012, 16: 61-67

[146] Muto S, Hata M, Taniguchi J et al. Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules. Proc Natl Acad Sci USA, 2010, 107: 8011-8016

[147] Yu AS, Enck AH, Lencer WI et al. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem, 2003, 278: 17350-17359

[148] Angelow S, Kim KJ, Yu AS. Claudin-8 modulates paracellular permeability to acidic and basic ions in MDCK II cells. J Physiol, 2006, 571: 15-26

[149] Balda MS, Whitney JA, Flores C et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol, 1996, 134: 1031-1049

[150] Ulluwishewa D, Anderson RC, McNabb WC et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr, 2011, 141: 769-776

[151] van der Helm MW, Odijk M, Frimat JP et al. Direct quantification of transendothelial electrical resistance in organs-on-chips. Biosens Bioelectron, 2016, 85: 924-929

[152] Srinivasan B, Kolli AR, Esch MB et al. TEER measurement techniques for in vitro barrier model systems. J Lab Autom, 2015, 20: 107-126

[153] Sumanasekera WK, Zhao L, Ivanova M et al. Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells. Cell Tissue Res, 2006, 324: 243-253

[154] Sumanasekera WK, Sumanasekera GU, Mattingly KA et al. Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity. Am J Physiol Cell Physiol, 2007, 293: C566-C573

[155] Ye L, Martin TA, Parr C et al. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol, 2003, 196: 362-369

[156] Hass MA, Nichol P, Lee L et al. Estrogen modulates permeability and prostaglandin levels in the rabbit urinary bladder. Prostaglandins Leukot Essent Fatty Acids, 2009, 80: 125-129

[157] Patrick DM, Leone AK, Shellenberger JJ et al. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol, 2006, 6: 2

[158] Kinugasa T, Sakaguchi T, Gu X et al. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology, 2000, 118: 1001-1011

[159] Anderson RC, Cookson AL, McNabb WC et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol, 2010, 10: 316

[160] Qin H, Zhang Z, Hang X et al. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol, 2009, 9: 63

[161] Ewaschuk JB, Diaz H, Meddings L et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol, 2008, 295: G1025-G1034

[162] Mennigen R, Nolte K, Rijcken E et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol, 2009, 296: G1140-G1149

[163] Peng L, Li ZR, Green RS et al. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr, 2009, 139: 1619-1625

[164] Panigrahi P, Braileanu GT, Chen H et al. Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology. World J Gastroenterol, 2007, 13: 6370-6378

[165] Ardita CS, Mercante JW, Kwon YM et al. Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses. Appl Environ Microbiol, 2014, 80: 5068-5077

[166] Jones RM, Luo L, Ardita CS et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J, 2013, 32: 3017-3028

[167] Han C, Ding Z, Shi H et al. The role of probiotics in lipopolysaccharide-induced autophagy in intestinal epithelial cells. Cell Physiol Biochem, 2016, 38: 2464-2478

[168] Kim YG, Lee CK, Nah SS et al. Human CD4⁺CD25⁺ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun, 2007, 357: 1046-1052

[169] Zaiss MM, Axmann R, Zwerina J et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum, 2007, 56: 4104-4112

[170] Yuan FL, Li X, Lu WG et al. Regulatory T cells as a potent target for controlling bone loss. Biochem Biophys Res Commun, 2010, 402: 173-176

[171] Luo CY, Wang L, Sun C et al. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol, 2011, 8: 50-58

[172] Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med, 2006, 203: 2673-2682

[173] Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev, 2005, 208: 194-206

[174] Nakamura T, Imai Y, Matsumoto T et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell, 2007, 130: 811-823

[175] Krum SA, Miranda-Carboni GA, Hauschka PV et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J, 2008, 27: 535-545

[176] Martin-Millan M, Almeida M, Ambrogini E et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol, 2010, 24: 323-334

[177] Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res, 2002, 57: 385-409

[178] Hughes DE, Dai A, Tiffee JC et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med, 1996, 2: 1132-1136

[179] Lelu K, Laffont S, Delpy L et al. Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol, 2011, 187: 2386-2393

[180] Chen JR, Plotkin LI, Aguirre JI et al. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem, 2005, 280: 4632-4638

[181] Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science, 2003, 300: 650-653

[182] Ozaki M, Suzuki S, Irani K. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J, 2002, 16: 889-890

[183] Kantengwa S, Jornot L, Devenoges C et al. Superoxide anions induce the maturation of human dendritic cells. Am J Respir Crit Care Med, 2003, 167: 431-437

[184] Grassi F, Tell G, Robbie-Ryan M et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA, 2007, 104: 15087-15092

[185] Lean JM, Davies JT, Fuller K et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest, 2003, 112: 915-923

[186] Cenci S, Toraldo G, Weitzmann MN et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA, 2003, 100: 10405-10410

[187] Gao Y, Grassi F, Ryan MR et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest, 2007, 117: 122-132

[188] Ryan MR, Shepherd R, Leavey JK et al. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci USA, 2005, 102: 16735-16740

[189] Yang NN, Venugopalan M, Hardikar S et al. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science, 1996, 273: 1222-1225

[190] Adeel S, Singh K, Vydareny KH et al. Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy. J Investig Med, 2013, 61: 1178-1183

[191] Ammann P, Rizzoli R, Bonjour JP et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest, 1997, 99: 1699-1703

[192] Charatcharoenwitthaya N, Khosla S, Atkinson EJ et al. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res, 2007, 22: 724-729

[193] D'Amelio P, Grimaldi A, Di Bella S et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone, 2008, 43: 92-100

[194] Sherman ML, Weber BL, Datta R et al. Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites. J Clin Invest, 1990, 85: 442-447

[195] Hofbauer LC, Lacey DL, Dunstan CR et al. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone, 1999, 25: 255-259

[196] Lam J, Takeshita S, Barker JE et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest, 2000, 106: 1481-1488

[197] Molnar I, Bohaty I, Somogyine-Vari E. IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis. Osteoporos Int, 2014, 25: 783-786

[198] Molnar I, Bohaty I, Somogyine-Vari E. High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency. Menopause, 2014, 21: 749-752

[199] Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr, 1998, 18: 117-143

[200] Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr, 1998, 128: 11-19

[201] Cox MA, Jackson J, Stanton M et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol, 2009, 15: 5549-5557

[202] Asarat M, Apostolopoulos V, Vasiljevic T et al. Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells. Int J Food Sci Nutr, 2015, 66: 755-765

[203] Asarat M, Apostolopoulos V, Vasiljevic T et al. Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest, 2016, 45: 205-222

[204] Kwon HK, Lee CG, So JS et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA, 2010, 107: 2159-2164

[205] Lavasani S, Dzhambazov B, Nouri M et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One, 2010, 5: e9009

[206] Thomas CM, Hong T, van Pijkeren JP et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One, 2012, 7: e31951

[207] Bouladoux N, Hall JA, Grainger JR et al. Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol, 2012, 5: 623-634

[208] Agata U, Park JH, Hattori S et al. The effect of different amounts of calcium intake on bone metabolism and arterial calcification in ovariectomized rats. J Nutr Sci Vitaminol (Tokyo), 2013, 59: 29-36

[209] Arjmandi BH, Hollis BW, Kalu DN. In vivo effect of 17 beta-estradiol on intestinal calcium absorption in rats. Bone Miner, 1994, 26: 181-189

[210] Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab, 1980, 51: 1359-1364

[211] Kalu DN, Chen C. Ovariectomized murine model of postmenopausal calcium malabsorption. J Bone Miner Res, 1999, 14: 593-601

[212] O'Loughlin PD, Morris HA. Oestrogen deficiency impairs intestinal calcium absorption in the rat. J Physiol, 1998, 511 Pt 1 313-322

[213] Schwartz B, Smirnoff P, Shany S et al. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem, 2000, 203: 87-93

[214] Liel Y, Shany S, Smirnoff P et al. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology, 1999, 140: 280-285

[215] Ten Bolscher M, Netelenbos JC, Barto R et al. Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat. J Bone Miner Res, 1999, 14: 1197-1202

[216] Van Cromphaut SJ, Rummens K, Stockmans I et al. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res, 2003, 18: 1725-1736

[217] Chonan O, Matsumoto K, Watanuki M. Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci Biotechnol Biochem, 1995, 59: 236-239

[218] Zafar TA, Weaver CM, Zhao Y et al. Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats. J Nutr, 2004, 134: 399-402

[219] Brennan O, Kuliwaba JS, Lee TC et al. Temporal changes in bone composition, architecture, and strength following estrogen deficiency in osteoporosis. Calcif Tissue Int, 2012, 91: 440-449

[220] Gambacciani M, Levancini M. Management of postmenopausal osteoporosis and the prevention of fractures. Panminerva Med, 2014, 56: 115-131

[221] Gaya P, Medina M, Sánchez-Jiménez A et al. Phytoestrogen metabolism by adult human gut microbiota. Molecules, 2016, 21: pii: E1034

[222] Uehara M. Isoflavone metabolism and bone-sparing effects of daidzein-metabolites. J Clin Biochem Nutr, 2013, 52: 193-201

[223] Ohtomo T, Uehara M, Penalvo JL et al. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur J Nutr, 2008, 47: 273-279

[224] Ishimi Y. Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice. J Nutr, 2010, 140: 1373s-1376s

[225] Tezval M, Sehmisch S, Seidlova-Wuttke D et al. Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol. Planta Med, 2010, 76: 235-240

[226] Legette LL, Prasain J, King J et al. Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats. J Agric Food Chem, 2014, 62: 1294-1300

[227] Tousen Y, Ezaki J, Fujii Y et al. Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial. Menopause, 2011, 18: 563-574

[228] Brink E, Coxam V, Robins S et al. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr, 2008, 87: 761-770

[229] Fujioka M, Uehara M, Wu J et al. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr, 2004, 134: 2623-2627

[230] Wang J, Xu J, Wang B et al. Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor. Genet Mol Res, 2014, 13: 5055-5063

[231] Tousen Y, Matsumoto Y, Matsumoto C et al. The combined effects of soya isoflavones and resistant starch on equol production and trabecular bone loss in ovariectomised mice. Br J Nutr, 2016, 116: 247-257

[232] Nishide Y, Tadaishi M, Kobori M et al. Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice. J Clin Biochem Nutr, 2013, 53: 41-48

[233] Kang JS, Yoon YD, Han MH et al. Estrogen receptor-independent inhibition of tumor necrosis factor-alpha gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kappaB activation in mouse macrophages. Biochem Pharmacol, 2005, 71: 136-143

[234] Guadamuro L, Dohrmann AB, Tebbe CC et al. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones. BMC Microbiol, 2017, 17: 93

[235] Possemiers S, Bolca S, Eeckhaut E et al. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol, 2007, 61: 372-383

[236] Bolca S, Wyns C, Possemiers S et al. Cosupplementation of isoflavones, prenylflavonoids, and lignans alters human exposure to phytoestrogen-derived 17beta-estradiol equivalents. J Nutr, 2009, 139: 2293-2300

[237] Yu ZT, Yao W, Zhu WY. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett, 2008, 282: 73-80

[238] Nakatsu CH, Armstrong A, Clavijo AP et al. Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS One, 2014, 9: e108924

[239] Decroos K, Vanhemmens S, Cattoir S et al. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol, 2005, 183: 45-55

[240] Fujii S, Takahashi N, Inoue H et al. A combination of soy isoflavones and cello-oligosaccharides changes equol/O-desmethylangolensin production ratio and attenuates bone fragility in ovariectomized mice. Biosci Biotechnol Biochem, 2016, 80: 1632-1635

[241] Ohta A, Uehara M, Sakai K et al. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr, 2002, 132: 2048-2054

[242] Mathey J, Mardon J, Fokialakis N et al. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteoporos Int, 2007, 18: 671-679

[243] Devareddy L, Khalil DA, Korlagunta K et al. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause, 2006, 13: 692-699

[244] Wu J, Oka J, Ezaki J et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause, 2007, 14: 866-874

[245] Hoy-Schulz YE, Jannat K, Roberts T et al. Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial. BMC Complement Altern Med, 2016, 16: 44

[246] Kitajima H, Hirano S. Safety of Bifidobacterium breve (BBG-01) in preterm infants. Pediatr Int, 2017, 59: 328-333

[247] Ladas EJ, Bhatia M, Chen L et al. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant, 2016, 51: 262-266

[248] Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 2008, 371: 651-659